Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Stroke Despite Oral Anticoagulant Therapy:

Alberto Preda1, Claudio Montalto2, Luigi De Luca3

  • 1De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy.

PubMed

Insights

Left atrial appendage closure (LAAC) combined with oral anticoagulation (OAC) offers better outcomes for atrial fibrillation patients experiencing cardioembolic stroke (CS) despite OAC. This hybrid strategy significantly reduces stroke recurrence compared to OAC alone.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Stroke Medicine

Background:

  • Atrial fibrillation (AF) patients with prior cardioembolic stroke (CS) despite adequate oral anticoagulation (OAC) present a clinical challenge.
  • Left atrial appendage closure (LAAC) is a potential intervention for these high-risk individuals.

Purpose of the Study:

  • To evaluate the safety and efficacy of a hybrid strategy combining LAAC and continued OAC in patients with OAC failure.
  • To compare outcomes of this hybrid strategy against medical therapy (MT) alone in patients with CS despite adequate OAC.

Main Methods:

  • A multicenter study comparing patients who underwent LAAC plus OAC versus MT alone after an index CS event while on adequate OAC.
  • Exclusion of other embolic sources and continuation of OAC for all participants.
  • Primary endpoint: composite of all-cause death, CS, and major bleeding.

Main Results:

  • The LAAC group (44 patients) showed a significantly lower rate of the primary endpoint (HR 0.398, p=0.008) and CS recurrence (HR 0.273, p=0.041) compared to the MT group (65 patients) at 48 months follow-up.
  • Annualized CS rate was 2.0 per 100 patient-years in the LAAC group versus 7.8 per 100 patient-years in the MT group.
  • CHA2DS2VA, NIHSS, and acute reperfusion therapy predicted the primary endpoint; CHA2DS2VA and NIHSS predicted CS recurrence. Propensity-score matching confirmed results.

Conclusions:

  • The hybrid strategy of LAAC plus OAC is associated with improved long-term outcomes in patients experiencing CS due to OAC failure.
  • This approach offers a superior alternative to OAC monotherapy for selected AF patients with recurrent stroke.
  • LAAC combined with OAC demonstrates significant potential in preventing recurrent cardioembolic events.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.2K
Surface Appendages of Archaea01:23

Surface Appendages of Archaea

Archaeal surface appendages are highly specialized structures essential for environmental adaptation, encompassing roles in adhesion, biofilm formation, and motility. Among these appendages, pili and archaella stand out for their distinct morphologies and functionalities, enabling archaea to thrive in diverse and often extreme environments.Pili: Adhesion and Biofilm FormationPili are filamentous structures assembled from pilin protein subunits, primarily contributing to adhesion and biofilm...
628
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.8K
Oral Cavity01:11

Oral Cavity

The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
146